MMedication Read More Ozempic and Wegovy May Slow Alcohol Absorption and IntoxicationNovember 7, 2025 November 6, 2025 4 min read Why Drugs Like Ozempic Can Make People Drink Less Alcohol A small…
MMedication Read More DVLA warning as drivers could lose licence over three common medicationsNovember 7, 2025 The DVLA has issued a warning to drivers, road users and motorists that they could have their driving…
MMedication Read More Texas AG Ken Paxton moves to block Tylenol maker dividend amid lawsuit over marketingNovember 7, 2025 Texas Attorney General Ken Paxton has filed a motion to block Kenvue, the maker of Tylenol, from issuing…
MMedication Read More Drug company representative collapses during Oval Office eventNovember 7, 2025 A representative from a drug manufacturer fainted during an event at the White House on Thursday, where President…
MMedication Read More Suburban chiropractor accused of secretly recording more than 100 patientsNovember 6, 2025 ST. CHARLES, Ill. (WGN) — A west suburban chiropractor is accused of secretly video taping his patients as…
MMedication Read More Atorvastatin Recall May Affect Hundreds of Thousands of Patients – and Reflects FDA’s Troubles Inspecting Medicines Made OverseasNovember 6, 2025 If you take cholesterol-lowering drugs called statins, you may have noticed a flurry of news coverage since late October 2025 about an…
MMedication Read More Over Half a Million Blood Pressure Pills Recalled: Is Yours on the List?November 6, 2025 If you or someone in your household takes blood pressure medication, now is the time to check your…
MMedication Read More Mark Cuban tries to shake up biosimilar pricing with a version of J&J’s StelaraNovember 6, 2025 In its latest bid to shake up the prescription drug market, the Mark Cuban Cost Plus Drug Company…
MMedication Read More FDA Approves Caplyta for Adjunctive Treatment of Major Depressive DisorderNovember 6, 2025 The US Food and Drug Administration (FDA) has approved Johnson & Johnson’s lumateprone (Caplyta) as an adjunctive therapy for…
MMedication Read More Weight loss gets cheaper: New White House deal slashes prices of Ozempic and Wegovy |November 6, 2025 The cost of some of the most widely used weight loss medications in the United States is set…
MMedication Read More New FDA priority review vouchers go to Lilly, Novo, VertexNovember 6, 2025 WASHINGTON — The Food and Drug Administration on Thursday announced the second batch of companies being granted a “Commissioner’s…
MMedication Read More Metsera Weight-Loss Drug Shows ‘Excellent’ Tolerability in StudyNovember 6, 2025 Metsera Inc.’s next-generation weight-loss drug showed good tolerability with few participants dropping out of a mid-stage trial, adding…